Skip to content

Linopirdine

NERVOUS SYSTEM

ATC N06BX09

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Linopirdine is a drug catalogued in DrugCentral. DrugCentral lists 5 molecular targets, including Kcnq3, KCNQ2 and KCNQ4.

  • Molecular targets: Kcnq3, KCNQ2, KCNQ4 and KCNQ5 (5 listed in DrugCentral).
  • ATC code: N06BX09 (Other psychostimulants and nootropics).
  • Molecular formula: C26H21N3O; molecular weight 391.47 g/mol.

Mechanism & targets

Molecular targets (5)

TargetGeneActionActivity
Potassium voltage-gated channel subfamily KQT member 3Kcnq3inhibitorIC50 5.40
Potassium voltage-gated channel subfamily KQT member 2KCNQ2blockerIC50 5.30
Potassium voltage-gated channel subfamily KQT member 4KCNQ4blockerIC50 4.90
Potassium voltage-gated channel subfamily KQT member 5KCNQ5blockerKd 4.80
Potassium voltage-gated channel subfamily KQT member 1Kcnq1inhibitorIC50 4.40

ATC classification

ATC codeTherapeutic hierarchy
N06BX09NERVOUS SYSTEM › PSYCHOANALEPTICS › PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS › Other psychostimulants and nootropics

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Linopirdine is on its molecule page.

Molecular formulaC26H21N3O
Molecular weight391.47 g/mol
CAS number105431-72-9
InChIKeyYEJCDKJIEMIWRQ-UHFFFAOYSA-N
PubChem CID3932
O=C1N(C2=CC=CC=C2C1(CC1=CC=NC=C1)CC1=CC=NC=C1)C1=CC=CC=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

How does Linopirdine work?

Its molecular targets in DrugCentral include Kcnq3 (inhibitor), KCNQ2 (blocker), KCNQ4 (blocker) and KCNQ5 (blocker).

What is the chemical formula of Linopirdine?

Linopirdine has the molecular formula C26H21N3O and a molecular weight of 391.47 g/mol.

Browse: all drugs starting with L · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
Agency—
Targets5
Indications0
FormulaC26H21N3O
DrugCentral ID4588
Interactive profile